All Stories

  1. Removing Race from Kidney Disease Diagnosis
  2. COVID-19 and AKI: Where Do We Stand?
  3. Measuring Up
  4. Intravenous Fluids
  5. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction
  6. Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade
  7. RRT in AKI: Start Early or Wait?
  8. Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study
  9. Modality of RRT and Recovery of Kidney Function after AKI in Patients Surviving to Hospital Discharge
  10. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial
  11. A New CJASN Series: Renal Immunology for the Clinician
  12. Biomarker Enhanced Risk Prediction for Adverse Outcomes in Critically Ill Patients Receiving RRT
  13. Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes
  14. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
  15. A New CJASN Series: Renal Physiology for the Clinician
  16. Renal Angina: Right Concept...Wrong Name?
  17. Sexual Function, Activity, and Satisfaction among Women Receiving Maintenance Hemodialysis
  18. AKI: A Path Forward
  19. Piecewise Analysis of Patient Survival after Onset of AKI
  20. Prevention of Contrast-Induced AKI: A Review of Published Trials and the Design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) Trial
  21. Introduction: Perspectives on Integrated Nephrology Care
  22. Comparison of Symptom Management Strategies for Pain, Erectile Dysfunction, and Depression in Patients Receiving Chronic Hemodialysis: A Cluster Randomized Effectiveness Trial
  23. Health-Related Quality of Life as a Predictor of Mortality among Survivors of AKI
  24. Designing Clinical Trials in Acute Kidney Injury